ADC Therapeutics (ADCT) Other financing activities (2023 - 2026)
ADC Therapeutics (ADCT) posted Other financing activities of $205000.0 for Q1 2026, down 98.6% sequentially from $14.6 million in Q4 2025, and down 24.35% YoY from $271000.0 in Q1 2025.
ADC Therapeutics (ADCT) Other financing activities (2023 - 2026) Analysis & Trends
ADC Therapeutics has reported Other financing activities for 4 years, with the latest figure at $205000.0 in Q1 2026.
- Quarterly Other financing activities fell 24.35% year-over-year to $205000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $65.3 million (up 77.11% YoY) and the FY2025 annual result came in at $65.4 million, up 77.04% from the prior year.
- Other financing activities retreated to $205000.0 in Q1 2026 per ADCT's latest filing, from $14.6 million in the prior quarter.
- Over five years, Other financing activities peaked at $50.5 million in Q2 2025 and troughed at -$1000.0 in Q4 2023.
- A 4-year average of $11.5 million and a median of $349000.0 in 2023 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2025 and 2026: Other financing activities surged 37.94% in 2025, then declined 24.35% in 2026.
- Over 4 years, Other financing activities stood at -$1000.0 in 2023, then soared by 3660300.0% to $36.6 million in 2024, then sank by 60.08% to $14.6 million in 2025, then tumbled by 98.6% to $205000.0 in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered $205000.0, $14.6 million, and $50.5 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | ADC Therapeutics | 154.55 Mn | -64.56 Mn | 17.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 118,000.00 |
| Jun 30, 2026 | 118,000.00 |
| Mar 31, 2026 | 205,000.00 |
| Mar 31, 2026 | 205,000.00 |
| Dec 31, 2025 | 14.61 Mn |
| Dec 31, 2025 | 14.61 Mn |
| Jun 30, 2025 | 50.49 Mn |
| Jun 30, 2025 | 50.49 Mn |
| Mar 31, 2025 | 271,000.00 |
| Mar 31, 2025 | 271,000.00 |
| Jun 30, 2024 | 36.60 Mn |
| Jun 30, 2024 | 36.60 Mn |
| Mar 31, 2024 | 323,000.00 |
| Mar 31, 2024 | 323,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Dec 31, 2023 | -1,000.00 |
| Sep 30, 2023 | 349,000.00 |
| Sep 30, 2023 | 349,000.00 |
| Mar 31, 2023 | 425,000.00 |
| Mar 31, 2023 | 425,000.00 |